A Phase I/II Study of KDX-0811(Dexrazoxane) in the Treatment of Accidental Extravasation of Anthracycline Anti-cancer Agents

NCT01596088 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

2

Enrollment

INDUSTRY

Sponsor class

Conditions

Extravasations of Anthracycline Anti-cancer Agents

Interventions

DRUG: Dexrazoxane

Sponsor

Kissei Pharmaceutical Co., Ltd.